Contagious illness of tuberculosis and correlation with various types of cancer

Tuberculosis is a contagious illness caused by the bacteria Mycobacterium tuberculosis . It spreads readily from one person to another through tiny particles called airborne droplet nuclei. Immunocompromised individuals are particularly susceptible to this infection. In this context, various types of leukemia, lymphoma, and lung carcinoma are linked with reinforces of tuberculosis. Similarly, the tuberculous granuloma is associated with the progression of the tumor significantly. However, the lung is the primary organ infected by tuberculosis, and the granuloma of this disease is reinforced to lung adenocarcinoma, Squamous cell carcinoma, and non-small cell lung cancer. Multiple studies have revealed the root cause of the spread of these two illnesses is attributed to the production of granulomas in the lungs, which in turn contributes to the development of both tuberculosis and lung cancer. Also, the clinical signs and symptoms of tuberculosis and other malignancies in various sites of the host represent severe complications, and diagnosis of these two diseases through adequate clinical testing is crucial. Computerized tomography and rapid diagnosis for cancer and tuberculosis are effective for controlling the disease progression, and timely detection helps to treat the patients. Thus, imaging techniques and molecular diagnosis are capable of providing precise diagnostic results. So, this review comprehensively analyzed the patients affected with tuberculosis in the lung and other sites that could progress the cancer, also reinforces of tuberculosis in patients with different types of cancer. • The incidence of subsequent lung cancer was 1.67 times higher in the TB cohort than in the non-TB cohort. • The lungs are the primary organ TB attacks, and its sign and symptoms are significantly linked to lung carcinoma. • Mycobacterium tuberculosis (MTB) PPD activates human lung inducible protein-10 (IP-10), a CXCR3 ligand. • Overtime, new TB patients have developed more cancers. Comparatively, it was 9% in 2005, 10% in 2010, and 13% in 2015.